| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250404 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250395 Antagonist peptides to VEGF receptor Flt-1 |
| 07/31/2007 | US7250299 Lentiviral packaging system and transfer vector; a heterologous gene operably linked to a regulatory element, vector that encodes a gag gene or a pol gene; and a regulatory lentiviral vector of a rev gene, |
| 07/31/2007 | US7250293 Complementing cell lines |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250275 LIF has a differentiation prevention function for a chicken differentiable cell such as a chicken's embryonic stem cell or embryonic reproductive cell, effective as an anti-differentiator while the chicken differentiable cell is being cultured |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | US7250262 For the diagnosis and treatment of patients with disorders including anemias |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250177 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
| 07/26/2007 | WO2007084740A2 Tat-030 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084715A2 Tat-031 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084708A2 Tat-028 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084684A2 Therapeutic uses of inhibitors of rtp801 |
| 07/26/2007 | WO2007084499A2 Disease control in shrimp |
| 07/26/2007 | WO2007084487A2 Pericytes for use as stem cells |
| 07/26/2007 | WO2007084354A2 Use of mesenchymal stem cells for treating genetic diseases and disorders |
| 07/26/2007 | WO2007084247A2 Stable therapeutic formulations |
| 07/26/2007 | WO2007084237A2 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
| 07/26/2007 | WO2007083094A1 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 07/26/2007 | WO2007082352A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 07/26/2007 | WO2007047718A3 Generation and use of vasculogenic tumors |
| 07/26/2007 | WO2007014134A3 Tandem cardiac pacemaker system |
| 07/26/2007 | WO2006102461A3 Influenza therapeutic |
| 07/26/2007 | WO2006083331A3 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070173477 Polypeptides and nucleic acid molecules encoding the polypeptide; such molecules have use as probes for diagnosis of Alzheimer's disease, and for identification of compounds that modulate the activity of beta secretase |
| 07/26/2007 | US20070173476 Exposing double stranded polynucleotide comprised of a sense strand and an antisense strand to target nucleic acid and wherein at least one strand comprises at least one orthoester modified nucleotide; medical diagnosis; genetic engineering |
| 07/26/2007 | US20070173475 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/26/2007 | US20070173474 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/26/2007 | US20070173473 RNA interference mediated inhibition of proprotein convertase subtilisin Kexin 9 (PCSK9) gene expression using short interfering nucleic acid (siNA) |
| 07/26/2007 | US20070173472 Methods and reagents for the treatment of apoptosis-related disorders |
| 07/26/2007 | US20070173471 Morphogen compositions and methods of use thereof to treat heart disorders |
| 07/26/2007 | US20070173470 Methods for delivering extracellular target into cells |
| 07/26/2007 | US20070173469 Administering immunomer comprising at least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a nonnucleotidic linker, at least one oligonucleotide an immunostimulant having accessible 5' end |
| 07/26/2007 | US20070173468 Lymphoblast proteolytic enzyme which is secreted from human b lymphoblastic cells and recognizes and destroys bacterial DNA; bactericides |
| 07/26/2007 | US20070173467 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 07/26/2007 | US20070173465 Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene |
| 07/26/2007 | US20070173456 Preptin fragments and methods of use |
| 07/26/2007 | US20070173439 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 07/26/2007 | US20070172948 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/26/2007 | US20070172884 Monitoring sample for preferential particles; obtain sample, incubate on test column, wash column, incubate with probes, wash column, detect signals; using chemiluminescence labels acridinium dye; diagnosing diseases by detect nucleic acid has been used for diseases associated with abnormal gene products |
| 07/26/2007 | US20070172830 Antibodies to hhpen62 polypeptide |
| 07/26/2007 | US20070172495 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172470 Phosphatase regulation of nucleic acid transcription |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172466 Method of replenishing cells damaged by treatment for cancer |
| 07/26/2007 | US20070172462 siRNA-mediated gene silencing of synuclein |
| 07/26/2007 | US20070172461 Polyepitope vaccines |
| 07/26/2007 | US20070172460 Random peptide library displayed on aav vectors |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172432 Biodegradable hemostatic compositions |
| 07/26/2007 | US20070172430 Dry powder compositions for rna influenza therapeutics |
| 07/26/2007 | CA2637350A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 07/26/2007 | CA2635251A1 Stable therapeutic formulations |
| 07/25/2007 | EP1811036A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811026A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1810978A2 Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof |
| 07/25/2007 | EP1810696A1 Gene therapy for treatment of cardiac failure |
| 07/25/2007 | EP1809745A2 COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAv1.8 |
| 07/25/2007 | EP1809337A2 Chimeric vectors |
| 07/25/2007 | EP1809336A2 Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 07/25/2007 | EP1200594B1 Protective antigen of epstein barr virus |
| 07/25/2007 | EP1141363B1 Target cell-specific adenoviral vectors containing e3 and methods of use thereof |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | EP0698092B1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 07/25/2007 | CN1328372C Tumor target gene-virus ZD55-IL-24, construction method and application thereof |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1327900C Attenuated typhoid bacillus vaccine of virus gene carried on chromosome and its preparation method |
| 07/25/2007 | CN1327899C Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases |
| 07/25/2007 | CN101006180A Virus particle containing a vector derived from alpha virus and its preparation method |
| 07/25/2007 | CN101006172A Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 07/25/2007 | CN101006171A Anticancer agent containing minus-strand RNA virus |
| 07/25/2007 | CN101005827A Methods and articles for the delivery of therapeutic agents |
| 07/25/2007 | CN101003816A Method for constructing straight nucleus expressed plasmid in PEX secretion type of human and application |
| 07/25/2007 | CN101003800A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 07/25/2007 | CN101002948A Peptide-DNA double vaccine based on T-cell epitope for anti-Schistosoma japonicum infection |
| 07/25/2007 | CN101002936A Vaccine for preventing flavivirus infection |
| 07/24/2007 | US7247718 Polypeptide which is not expressed on normal, mature myeloid cells, for isolating cell suspensions from human blood and marrow for use in bone marrow transplantation, gene therapy and in treating diseases |
| 07/24/2007 | US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/24/2007 | US7247716 Recombinant sequence, its preparation and use |
| 07/24/2007 | US7247709 Mitogenic oxygenases |
| 07/24/2007 | US7247620 preventive therapy using nucleic acid coding a protein |